Patent ID: 8709434

Claim:
A phycochemical composition for administration to a mammalian subject, phycochemical composition having a prodrug activity for inhibiting NADPH oxidase activity, the phycochemical composition comprising: an isolated phycobilin dissolved or suspended within a pharmaceutically acceptable carrier and a capsule having a gelatinous case for containing said isolated phycobilin, said isolated phycobilin being converted to a phycorubin when administered to said mammalian subject for inhibiting NADPH oxidase activity, said isolated phycobilin being selected from the group consisting of phycocyanobilin, phycoerythrobilin, and phytochromobilin, said phycobilin including a peptide fragment of a phycocyanin conjugated thereto to form a peptide conjugated phycobilin, the peptide fragment being 100 amino acids in length or less, the peptide conjugated phycobilin being substantially purified.